Etoricoxib reduced pain and disability and improved quality of life in patients with chronic low back pain: a 3 month, randomized, controlled trial

Scandinavian Journal of Rheumatology
R M PallayGregory P Geba

Abstract

Chronic low back pain (LBP) is a growing health problem. Non-steroidal anti-inflammatory drugs (NSAIDs) are used to treat this condition, but have not demonstrated efficacy beyond 2 weeks, and no studies have shown that NSAIDs produce durable improvements in disability. To evaluate the efficacy and durability of effect of etoricoxib for chronic LBP, a randomized, double blind, placebo-controlled trial was conducted at 46 centres. Three hundred and twenty-five patients with chronic LBP requiring treatment with an NSAID or paracetamol were randomized 1:1:1 to etoricoxib 60 mg (n=109), 90 mg (n=106), or placebo (n=110), daily for 3 months. Pre-specified endpoints over 3 months included LBP intensity scale (visual analog scale 0-100 mm) time-weighted average change from baseline, the Roland-Morris Disability Questionnaire (RMDQ), the LBP bothersomeness scale, patient and investigator global assessments, and measures of quality of life. Both etoricoxib groups experienced significant reductions in LBP intensity at 4 weeks versus placebo [-15.15 mm and -13.03 mm for 60 and 90 mg, respectively, probability (p)<0.001 for each], which was maintained over 3 months. Treatment resulted in significant improvement from baseline compared to pl...Continue Reading

References

Mar 1, 1989·Journal of Clinical Psychology·M D Ackerman, M J Stevens
Jul 1, 1983·Journal of Clinical Psychology·D C Garron, F Leavitt
Mar 1, 1984·The New England Journal of Medicine·D M Clive, J S Stoff
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Aug 1, 1996·Rheumatic Diseases Clinics of North America·D G Borenstein
Apr 21, 1998·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·M R Underwood
Dec 8, 1996·Journal of Health Services Research & Policy·C Jenkinson, R Layte
Jun 18, 1999·BMJ : British Medical Journal·E ThomasG J Macfarlane
Sep 2, 1999·Lancet·G B Andersson
Mar 17, 2001·Scandinavian Journal of Rheumatology·F McKennaG S Geis
Oct 9, 2001·Clinical Therapeutics·A L Weaver
Feb 16, 2002·Scandinavian Journal of Rheumatology·N YeomansI Wiklund

❮ Previous
Next ❯

Citations

Dec 2, 2005·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Maurits W van TulderAntti Malmivaara
Jul 11, 2007·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·A KellerM van Tulder
Apr 19, 2008·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·L A C MachadoJ H McAuley
Mar 17, 2009·Journal of Public Health·E Chilet-RosellJ F Horga
Jun 25, 2005·Journal of Vascular Research·Florian KrotzHae-Young Sohn
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Marta L CaponePaola Patrignani
Feb 3, 2007·Current Medical Research and Opinion·Sean P CurtisAlise S Reicin
Nov 19, 2013·Revista da Associação Médica Brasileira·UNKNOWN Associação Brasileira de Medicina Física e Reabilitação
Nov 30, 2005·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Eustachio NettisAlfredo Tursi
Oct 28, 2008·Progress in Neurobiology·A Vania ApkarianPaul Y Geha
Jan 1, 2008·The Spine Journal : Official Journal of the North American Spine Society·Gerard Malanga, Erin Wolff
Mar 18, 2005·Seminars in Dialysis·Archana K ShayamsunderPaul L Kimmel
Dec 21, 2006·Journal of Clinical Pharmacy and Therapeutics·L-C Chen, D M Ashcroft
May 28, 2008·Pharmacotherapy·Christopher M HerndonUNKNOWN Ambulatory Care, Cardiology, and Pain and Palliative Care Practice and Research Networks of the American College of Clinical
Aug 26, 2015·BMC Musculoskeletal Disorders·Christoph WeberOliver Christ
Dec 12, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Ronald C WielageMichael Happich
Mar 23, 2010·Pain·R Andrew MooreHenry J McQuay
Jun 9, 2016·The Cochrane Database of Systematic Reviews·Bruno T SaragiottoChristopher G Maher
Feb 11, 2016·The Cochrane Database of Systematic Reviews·Wendy T M EnthovenBart W Koes
Feb 6, 2017·Annals of the Rheumatic Diseases·Gustavo C MachadoManuela L Ferreira
Nov 14, 2007·European Journal of Clinical Pharmacology·Shaojun Shi, Ulrich Klotz
Jun 27, 2008·Spine·Pepijn D D M RoelofsMaurits W van Tulder
May 21, 2013·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Hélène CawstonMichael Happich
Jan 25, 2020·Journal of Occupational and Environmental Medicine·Kurt T HegmannJeffrey S Harris
Aug 29, 2020·Journal of Patient-reported Outcomes·Claire BurbridgeElizabeth Nicole Bush
Apr 2, 2015·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Jessica J WongAnne Taylor-Vaisey
Jul 5, 2013·Current Opinion in Neurology·A Vania ApkarianMelissa A Farmer
Feb 7, 2008·The Cochrane Database of Systematic Reviews·P D D M RoelofsM W van Tulder
May 5, 2021·Expert Opinion on Drug Safety·Filip JovanovicNebojsa Nick Knezevic
Aug 31, 2021·BioMed Research International·Caiping YanYuling Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.